US tests vaccine against COVID-19 in humans

US Quickly Seeks COVID-19 Vaccine

US Quickly Seeks COVID-19 Vaccine.

“Phase 1 of the clinical trial to evaluate an investigational vaccine designed for coronavirus disease 2019 (COVID-19) has begun at the Kaiser Permanente Washington Health Research Institute in Seattle (KPWHRI),” the NIH said, They finance this project through one of its centers, the National Institute of Allergy and Infectious Diseases (NIAID).

Experts administered the vaccine on Monday to the first of 45 volunteers, all of them healthy adults between the ages of 18 and 55, who will take part in this experiment over six weeks.

The vaccine is called RNA-1273 and has been developed by scientists from NIAID and the modern biotechnology company.

The different doses of this experimental vaccine are being evaluated in this study for safety and its ability to induce an immune response in volunteers.

NIAID Director Anthony Fauci explained in the note that “finding a safe and effective vaccine to prevent SARS-CoV-2 infection is an urgent public health priority.”

Currently there is no vaccine approved by health authorities to prevent infection.

Pfizer's vaccine will be available in UK next week

Pfizer's vaccine will be available in UK next week The UK has become the first Western country to approve a Read more

Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective

Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective Moderna Inc said it will request authorization for emergency use in Read more

Pfizer's coronavirus vaccine sparks optimism

Pfizer's coronavirus vaccine sparks optimism. The European Commission announced this Wednesday an agreement reached with the pharmaceutical firms Pfizer and Read more

Pfizer’s late-stage coronavirus vaccine trial is near complete

Pfizer’s late-stage coronavirus vaccine trial is near complete. The countdown to the arrival of the Covid vaccine has begun. Pfizer Read more

45 vaccine candidates in human trials

45 vaccine candidates in human trials. Governments, companies, health systems and citizens scrutinize with great interest to know when a Read more

Moderna prepares for the "commercial launch" of its vaccine

Moderna prepares for the "commercial launch" of its vaccine. Modern biotechnology begins the procedures to request the authorization of its Read more

Moderna claims its COVID-19 vaccine produces a "robust" immune response

Moderna claims its COVID-19 vaccine produces a "robust" immune response. Scientists around the world will continue to search for a Read more

In his speech on Friday, the president of the Federal Reserve of the United States, Jerome Powell admitted that, although Read more

The European Union approves extraordinary funds of 750 billion for recovery after the pandemic

The European Union approves extraordinary funds of 750 billion for recovery after the pandemic.   With a «We did it! Read more

CytoDyn rejected by the FDA

CytoDyn rejected by the FDA. The FDA rejected CytoDyn’s application for its lead program, an antibody to treat HIV in Read more

Leave a Reply